跳至主要内容
临床试验/PACTR201804003249274
PACTR201804003249274已完成未知

Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with angiotensin II receptor antagonist undergoing coronary artery bypass graft surgery: a randomized controlled study

Ain Shams University Hospitals0 个研究点目标入组 100 人开始时间: 2018年3月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 Year(s) 至 80 Year(s)(—)
性别
All

入选标准

  • patients on angiotensin II receptor antagonist losartan for at least 4 weeks before operation
  • normal or mild impairment of left ventricular function (EF ¿ 40 by transthoracic echocardiography).

排除标准

  • Patients with a critical preoperative state were excluded from the study, including patients with intractable ventricular arrhythmias, previous aborted sudden cardiac death, preoperative mechanical ventilation, preoperative use of inotropes, preoperative use of intra-aortic balloon counter-pulsation, recent myocardial infarction. Patients with previous cardiac surgery, associated valvular heart disease, chronic lung disease, extra-cardiac arteriopathy, moderate to severe renal impairment were also excluded.

研究者

相似试验